En español
NIDA

NIDA announces new awards for the Clinical Trials Network

Announcement

October 08, 2015

National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials

The National Institute on Drug Abuse (NIDA) is pleased to announce the award of 13 grants to fund the continuation of the National Drug Abuse Treatment Clinical Trials Network (CTN).  The CTN provides a means by which treatment providers, researchers, and community-based service providers develop, validate, and deliver new treatment options to patients. The grants will support studies on behavioral and pharmacological therapeutic interventions in rigorous, multi-site clinical trials to determine their effectiveness across a broad range of community-based treatment settings and diversified patient populations. The research findings will be shared with physicians, clinicians, providers and patients in order to help bridge the gap between research findings and treatment.

The CTN framework consists of 13 Nodes, a Clinical Coordinating Center, and a Data and Statistics Center. This framework links a variety of treatment providers and patient populations nationwide, allowing for rapid testing of promising science-based therapies and the subsequent delivery of these treatments to patients in a variety of treatment settings.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.

Awardees are listed below:

  1. Florida Node Alliance - UG1 DA013720
    University of Miami - José Szapocznik, PhD
    Columbia University - Lisa Metsch, PhD
  2. Greater New York Node - UG1 DA013035
    New York University School of Medicine - John Rotrosen, MD
    New York State Psychiatric Institute/Columbia - Edward Nunes, Jr, MD
  3. Health Systems Node - UG1 DA040314
    Kaiser Foundation Research Institute - Cynthia Campbell, PhD, MPH
    University of California, San Francisco - Constance Weisner, DrPH, MSW
    Group Health Research Institute - Katharine Bradley, MD, MPH
  4. Mid-Atlantic Node - UG1 DA013034
    The Johns Hopkins University - Maxine Stitzer, PhD
    Friends Research Institute - Robert Schwartz, MD
  5. Mid-Southern Node - UG1 DA040317
    Duke University  - Li-Tzy Wu, ScD, RN, MA and Rowena Dolor, MD, MHS
  6. New England Node - UG1 DA015831
    McLean Hospital - Harvard Medical School - Roger Weiss, MD
    Yale University - Kathleen Carroll, PhD
  7. Northeast Node - UG1 DA015831
    Dartmouth College - Lisa Marsch, PhD
  8. Northstar Node - UG1 DA040316
    The Minneapolis Medical Research Foundation - Gavin Bart, MD, PhD
    University of Minnesota - Anne Joseph, MD, MPH
  9. Ohio Valley Node - UG1 DA013732
    University of Cincinnati - Theresa Winhusen, PhD
  10. Pacific Northwest Node - UG1 DA013714
    University of Washington - Dennis Donovan, PhD
  11. Southern Consortium Node - UG1 DA013727
    Medical University of South Carolina - Kathleen Brady, MD, PhD and Matthew Carpenter, PhD
  12. Texas Node - UG1 DA020024
    The University of Texas SW Med Center - Madhukar Trivedi, MD
  13. Western States Node - UG1 DA015815
    University of California, San Francisco - James Sorensen, PhD
    Oregon Health & Science University - Dennis McCarty, PhD

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

Nov 2016

Oct 2016

Sep 2016

Aug 2016

Jul 2016

Jun 2016

May 2016

Apr 2016

Mar 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

Jun 2015

May 2015

Apr 2015

Mar 2015

Feb 2015

Jan 2015

Dec 2014

Nov 2014

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

    Cite this article

    APA style citation

    NIDA (). NIDA announces new awards for the Clinical Trials Network. Retrieved , from https://www.drugabuse.gov/news-events/news-releases/2015/10/nida-announces-new-awards-clinical-trials-network

    press ctrl+c to copy
    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science